Cases & Deals

  • Home
  • Practices
  • IntegraGen’s shareholders sell majority interest to OncoDNA in tender offer

Share

IntegraGen’s shareholders sell majority interest to OncoDNA in tender offer

November 2020

Client(s) IntegraGen

Jones Day advised IntegraGen, a biotechnology company developing molecular markers for central nervous system and metabolic diseases, in connection with the public tender offer of shares by OncoDNA, a private health technology and precision medicine company focused on oncology.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.